Division of Cell Therapy
Introduction:
We are currently working on gene- and cell-mediated cancer therapy, which includes replication-competent adenoviruses and cytokines that enhance antigen presentation. These coordinately generate systemic immunity against putative tumor antigens. The projects are at this moment in a preclinical stage but hopefully will be forwarded to an investigator IND (Investigational New Drug) level.
Key Words: Gene therapy, Oncolytic adenovirus, Cytokine, Interferon, Dendritic cells, Immune responses, Clinical trials
Members:

HeadMasatoshi Tagawa
Senior ResearcherKiyoko Kawamura
Graduate StudentMakako Yamanaka
Shinya Okamoto
Graduate School of Medicine, Chiba University
Shan Yang
Suguru Yamauchi
Visiting ResearcherWenchang Li
Technical AssistantAkiko Fukuda
Research projects:

Immunology-based cancer gene therapy
Our purpose is to develop a novel therapeutic strategy with patient –friendly technology. See current ISCGT web site at
http://www.iscgt.net/index.html.
![]()
Chiba Cancer Center(Japanese) > Research Institute > Chiba Cancer Center Research Institute Organization > Division of Cell Therapy

